摘要
肝癌是严重威胁人类身心健康的一种临床疾病,因其有着较高的发病率和死亡率,对其进行有效的控制,延长生存期成为了研究热点。仑伐替尼是近年来肿瘤治疗的热门药物,关于中晚期肝癌的研究成果也越来越丰富,本研究结合相关研究成果进行综述。
Liver cancer is a clinical disease which seriously threatens human health.Because of its high incidence rate and mortality rate,effective control and prolonging the survival time have become a hot topic.Lenvatinib is a popular drug for cancer treatment in recent years,and the research results of advanced liver cancer are more and more abundant.This study reviews the related research results.
作者
何韬宸
HE Tao-chen(Fudan University,Shanghai 200433,China)
出处
《中国实用医药》
2022年第7期205-208,共4页
China Practical Medicine
关键词
仑伐替尼
中晚期肝癌
研究进展
Lenvatinib
Advanced liver cancer
Research progress
